Artal Group
Latest statistics and disclosures from Artal Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CAVA, LXRX, and represent 100.00% of Artal Group's stock portfolio.
- Artal Group has $715M in assets under management (AUM), dropping by -5.75%.
- Central Index Key (CIK): 0001053906
Tip: Access up to 7 years of quarterly data
Positions held by Artal Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Artal Group
Artal Group holds 2 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cava Group Ord (CAVA) | 78.1 | $558M | 9.5M | 58.69 |
|
|
| Lexicon Pharmaceuticals Com New (LXRX) | 21.9 | $157M | 136M | 1.15 |
|
Past Filings by Artal Group
SEC 13F filings are viewable for Artal Group going back to 2012
- Artal Group 2025 Q4 filed Feb. 12, 2026
- Artal Group 2025 Q3 filed Nov. 12, 2025
- Artal Group 2025 Q2 filed Aug. 13, 2025
- Artal Group 2025 Q1 filed May 14, 2025
- Artal Group 2024 Q4 filed Feb. 14, 2025
- Artal Group 2024 Q3 filed Nov. 13, 2024
- Artal Group 2024 Q2 filed Aug. 14, 2024
- Artal Group 2024 Q1 restated filed May 17, 2024
- Artal Group 2024 Q1 filed May 13, 2024
- Artal Group 2023 Q4 filed Feb. 9, 2024
- Artal Group 2023 Q3 filed Nov. 13, 2023
- Artal Group 2023 Q2 filed Aug. 11, 2023
- Artal Group 2023 Q1 filed May 12, 2023
- Artal Group 2022 Q4 filed Feb. 13, 2023
- Artal Group 2022 Q3 filed Nov. 14, 2022
- Artal Group 2022 Q2 filed Aug. 11, 2022